Chronic Diabetic Foot Ulcers
9
0
0
3
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
33.3%
3 terminated out of 9 trials
50.0%
-36.5% vs benchmark
56%
5 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Beta Adrenergic Antagonist for the Healing of Chronic DFU
Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer
Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds
Shockwave Treatment of Diabetic Foot Ulcer: Step I
Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers
Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers